Basel Medical Group issues 6,000,000 share purchase warrants in US$ 7.98 million offering
Bitget2026/10/08 17:17Basel Medical Group priced a registered direct offering of 6,000,000 units at US$ 1.33 per unit. Each unit includes one ordinary share or one Pre-Funded Warrant, plus one Common Warrant to buy one ordinary share. Common Warrants become exercisable immediately at 110% of the unit price, expire five years from issuance. Pre-Funded Warrants carry a US$ 0.01 exercise price, remain exercisable until fully exercised, subject to 4.99% or 9.99% ownership caps. Offering implies 6,000,000 Common Warrants outstanding; ordinary shares outstanding rise to 7,582,111 immediately upon completion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081317PRIMZONEFULLFEED9842380) on October 08, 2026, and is solely responsible for the information contained therein.
- Basel Medical Group priced a registered direct offering of 6,000,000 units at US$ 1.33 per unit.
- Each unit includes one ordinary share or one Pre-Funded Warrant, plus one Common Warrant to buy one ordinary share.
- Common Warrants become exercisable immediately at 110% of the unit price, expire five years from issuance.
- Pre-Funded Warrants carry a US$ 0.01 exercise price, remain exercisable until fully exercised, subject to 4.99% or 9.99% ownership caps.
- Offering implies 6,000,000 Common Warrants outstanding; ordinary shares outstanding rise to 7,582,111 immediately upon completion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

